Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2006; 27(01): 8-14
DOI: 10.1055/s-0041-1733144
Original Article

Hairy Cell Leukemia : Experience at a Tertiary Cancer Centre in Northern India

Kunjahari Medhi
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
,
Lalit Kumar
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
,
Atul Sharma
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
,
Vinod Raina
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
,
V Kochupillai
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
,
R Dawar
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
,
E Sreedhar
Department of Medical Oncology & Pathology, Institute Rotary, Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
23 March 2022

© 2006. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Bouroncl BA, Wiseman BK, Doan CA: Leukemic reticuloendotheliosis. Blood 1958;13:609-630.
  • 2 Cordone I, Annino L, Masi S, et al. Diagnostic relevance of peripheral blood immunocytochemistry in hairy cell leukemia. J Clin Pathol 1995;48:955.
  • 3 Pettitt AR, Zuzel M and Cawley JC. Hairy cell leukemia: Biology and management. Brit J Haematol 1999;106:2-8.
  • 4 Magee MJ, McKenzie S, Filippa DA, et al. Hairy cell leukemia: Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients. Cancer 1985;56:2557.
  • 5 Golomb HM, Jacobs A, Fofer A, et al. a-2 interferon therapy of hairy cell leukemia: a multicenter study of 64 patients. J Clin Oncol 1986;4:900.
  • 6 Grever M, Kopecky K, Foucar MK, et al. Randomized comparison of pentostatin versus interferon a-2a in previously untreated patients with hairy cell leukemia. An intergroup study. J Clin Oncol 1995;13:974.
  • 7 Piro LD, Carrera CJ, Carson DA. Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990;322:1117-21.
  • 8 Abhyankar D, Bajpai S, Saikia T, et al. 2-CdA in the treatment of Hairy cell leukemia. JAPI 2001;49:785-787.
  • 9 Jayanth ST, Prasad R, Mathews V, et al. Treatment of hairy cell leukemia with 2-Chloro-Deoxyyadenosine. Ind J Hemat & Blood Transf 2004;22: 28 (abst).
  • 10 Cheson BD, Sorensen M, Vena DA, et al. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the group C protocol mechanism of National Cancer Institute: a report of 979 patients. J Clin Oncol 1998;16:3007-15.
  • 11 Hoffrman MA, Janson D, Rose E, et al. Treatment of hairy cell leukemia with cladribine: Response, toxicity and long-term follow up. J Clin Oncol 1997;15:1138-1142.
  • 12 Goodman GR, Burian C, James A, et al. Extended follow up of patients with hairy cell leukemia after treatment with cladribine. J Clin Oncol 2003;21(5):891-896.
  • 13 Chadha P, Rademaker AW, Mendiratta P, et al.Treatment of hairy cell leukemia with 2- chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005;106(1):241-6.
  • 14 Thomas DA, O'Brien S, Bueso-Ramos C, et al. Rituximab in relapsed or refractory hairy cell leukemia.Blood 2003;102(12):3906-11.
  • 15 Kantarjian HM, Schachner J, Keating MJ. Fludarabine therapy in hairy cell leukemia. Cancer 1991;67:1291.
  • 16 Alan Saven, Burian C, Adusumalli J, et al. Filgrastim for cladribine induced neutropenic fever in patients with hairy cell leukemia. Blood 1999;93:2471-7.
  • 17 Ravandi F, O'Brien S. Infections associated with purine analogs and monoclonal antibodies. Blood Rev. 2005;(5):253-73.